Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity

被引：44

作者：

Tam, Eric M. ^{[1
]}

Fulton, Ross B. ^{[1
]}

Sampson, James F. ^{[1
]}

Muda, Marco ^{[1
]}

Camblin, Adam ^{[1
]}

Richards, Jennifer ^{[1
]}

Koshkaryev, Alexander ^{[1
]}

Tang, Jian ^{[1
]}

Kurella, Vinodh ^{[1
]}

Jiao, Yang ^{[1
]}

Xu, Lihui ^{[1
]}

Zhang, Kathy ^{[1
]}

Kohli, Neeraj ^{[1
]}

Luus, Lia ^{[1
]}

Hutto, Elizabeth ^{[2
]}

Kumar, Sandeep ^{[1
]}

Lulo, James ^{[1
]}

Paragas, Violette ^{[1
]}

Wong, Christina ^{[1
]}

Suchy, James ^{[1
]}

Grabow, Stephanie ^{[1
]}

Dugast, Anne-Sophie ^{[1
]}

Zhang, Hong ^{[1
]}

Depis, Fabien ^{[1
]}

Feau, Sonia ^{[1
]}

Jakubowski, Aniela ^{[1
]}

Qiao, Wenlian ^{[1
]}

Craig, Galina ^{[1
]}

Razlog, Maja ^{[1
]}

Qiu, James ^{[1
]}

Zhou, Yu ^{[3
]}

Marks, James D. ^{[3
]}

Croft, Michael ^{[4
,5
]}

Drummond, Daryl C. ^{[1
]}

Raue, Andreas ^{[1
]}

机构：

[1] Merrimack Pharmaceut Inc, Cambridge, MA 02139 USA

[2] Histosci Res Labs, Mt Jackson, VA 22842 USA

[3] Univ Calif San Francisco, San Francisco, CA 94110 USA

[4] La Jolla Inst Immunol, La Jolla, CA 92037 USA

[5] Univ Calif San Diego, La Jolla, CA 92037 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2019年 / 11卷 / 512期

关键词：

TUMOR-NECROSIS-FACTOR; FC-GAMMA RECEPTORS; EXPRESSION; MOUSE; EFFECTOR; CANCER; COSTIMULATOR; ANTI-PD-L1; BLOCKADE; SURVIVAL;

D O I：

10.1126/scitranslmed.aax0720

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Tumor necrosis factor receptor 2 (TNFR2) is the alternate receptor for TNF and can mediate both pro- and anti-inflammatory activities of T cells. Although TNFR2 has been linked to enhanced suppressive activity of regulatory T cells (T-regs) in autoimmune diseases, the viability of TNFR2 as a target for cancer immunotherapy has been under-appreciated. Here, we show that new murine monoclonal anti-TNFR2 antibodies yield robust antitumor activity and durable protective memory inmultiplemouse cancer cell linemodels. The antibodies mediate potent Fc-dependent T cell costimulation and do not result in significant depletion of T-regs. Corresponding human agonistic monoclonal anti-TNFR2 antibodies were identified and also had antitumor effects in humanized mousemodels. Anti-TNFR2 antibodies could be developed as a novel treatment option for patients with cancer.

引用

页数：15

共 50 条

[1] Enhanced Requirement for TNFR2 in Graft Rejection Mediated by Low-Affinity Memory CD8+ T Cells during Heterologous Immunity
Krummey, Scott M.
Chen, Ching-Wen
Guasch, Sara A.
Liu, Danya
Wagener, Maylene
Larsen, Christian P.
Ford, Mandy L.
JOURNAL OF IMMUNOLOGY, 2016, 197 (05): : 2009 - 2015
[2] Antibody-Suppressor CD8+ T Cells Ameliorate Antibody-Mediated Rejection Following Kidney Transplant in Mice
Zimmerer, J. M.
Han, J. L.
Zeng, Q.
Ringwald, B. A.
Cassol, C.
Warren, R.
Abdel-Rasoul, M.
Breuer, C. K.
Bumgardner, G. L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 697 - 697
[3] Antibody-suppressor CD8+ T cells ameliorate antibody-mediated rejection following kidney transplant in mice
Han, Jing Light
Zimmerer, Jason M.
Zeng, Qiang
Ringwald, Bryce A.
Cassol, Clarissa
Warren, Robert T.
Abdel-Rasoul, Mahmoud
Breuer, Christopher K.
Bumgardner, Ginny L.
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[4] Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation
Ayasoufi, Katayoun
Zwick, Daniel B.
Fan, Ran
Hasgur, Suheyla
Nicosia, Michael
Gorbacheva, Victoria
Keslar, Karen S.
Min, Booki
Fairchild, Robert L.
Valujskikh, Anna
JCI INSIGHT, 2019, 4 (07)
[5] Activated CD8+ T Cells Induce Expansion of Vβ5+ Regulatory T Cells via TNFR2 Signaling
Joedicke, Jara J.
Myers, Lara
Carmody, Aaron B.
Messer, Ronald J.
Wajant, Harald
Lang, Karl S.
Lang, Philipp A.
Mak, Tak W.
Hasenkrug, Kim J.
Dittmer, Ulf
JOURNAL OF IMMUNOLOGY, 2014, 193 (06): : 2952 - 2960
[6] Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
Tsukumo, Shin-ichi
Yasutomo, Koji
FRONTIERS IN IMMUNOLOGY, 2018, 9
[7] RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunity
Bogang Wu
Xiaowen Zhang
Huai-Chin Chiang
Haihui Pan
Bin Yuan
Payal Mitra
Leilei Qi
Hayk Simonyan
Colin N. Young
Eric Yvon
Yanfen Hu
Nu Zhang
Rong Li
Nature Communications, 13
[8] RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunity
Wu, Bogang
Zhang, Xiaowen
Chiang, Huai-Chin
Pan, Haihui
Yuan, Bin
Mitra, Payal
Qi, Leilei
Simonyan, Hayk
Young, Colin N.
Yvon, Eric
Hu, Yanfen
Zhang, Nu
Li, Rong
NATURE COMMUNICATIONS, 2022, 13 (01)
[9] Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells
Jiang, Da
Huang, Aiqi
Zhu, Bai-Xi
Gong, Jiangling
Ruan, Yong-Hao
Liu, Xing-Chen
Zheng, Limin
Wu, Yan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
[10] Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells
Chen, Yichen
Ma, Da
Wang, Xi
Fang, Juan
Liu, Xiangqi
Song, Jingjing
Li, Xinye
Ren, Xianyue
Li, Qiusheng
Li, Qunxing
Wen, Shuqiong
Luo, Liqun
Xia, Juan
Cui, Jun
Zeng, Gucheng
Chen, Lieping
Cheng, Bin
Wang, Zhi
CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) : 123 - 135

← 1 2 3 4 5 →